On April 26th, Chengyi Pharmaceutical signed a distribution agreement with Hainan Chengmei Pharmaceutical Co., Ltd. to cooperate with multiple hospitals under Hainan First Chengmei Medical Industry Group on the entry of the leading brand "Vasepa" product of "ultra pure fish oil". This is an important achievement for Chengyi Pharmaceutical's fish oil soft capsule health food since its sales in online channels such as JD flagship stores and WeChat mall at the beginning of the year. Chengyi Pharmaceutical's fish oil products have entered the online and internal channels.
Yao Lijun (third from left), General Manager of Hainan Chengmei Pharmaceutical Co., Ltd., and his delegation visited and guided Chengyi Pharmaceutical
As a senior domestic enterprise specializing in the development and service of marine biopharmaceuticals, Chengyi Pharmaceutical is one of the earliest pharmaceutical companies in China to involve the production of high-purity fish oil using super chromatography technology. With the support of national policies to strengthen the development of marine resources, promote the research and development of marine biotechnology, and promote industrialization, in recent years, Chengyi Pharmaceutical has promoted the "two strong and one large" strategy, strengthened the entire industrial chain of marine biopharmaceutical "glucosamine hydrochloride" and the entire industrial chain of high-purity fish oil health food and medicine, expanded the "big health industry", continuously thickened the company's marine biopharmaceutical types and product specifications, and strengthened the core competitiveness of the enterprise, Assist the national health cause. On August 24th last year, it obtained the first "Health Food Production License" in Wenzhou, becoming the first health food production enterprise in Wenzhou, achieving a "zero breakthrough" in the production of health food in Wenzhou; After the National Day holiday, the company's 0.5g "Sankang" and 1g "Vasepa" fish oil soft capsule health food with two specifications and an EPA content of over 93% were successfully approved. On December 29th, the first batch of 5025 high-purity fish oil soft capsule health food was successfully launched. Since its launch, the product has been highly favored by consumers due to its significant therapeutic effect, contributing to the maintenance of cardiovascular and cerebrovascular health in middle-aged and elderly people. At present, the company is rushing to apply for pharmaceutical grade fish oil EPA products, striving to return to domestic and foreign consumers as soon as possible.
According to data, Hainan Chengmei Pharmaceutical Co., Ltd. is a pharmaceutical equipment supply chain integrated service provider under Hainan First Chengmei Medical Industry Group. The group is a leader in Hainan's big health industry, actively practicing the "Healthy China" strategy, actively participating in the construction of "Healthy Hainan", creating a big health industry cluster, and providing high-quality medical services. Its business scope covers hospital operation management, rehabilitation and recuperation, physical examination and health management Medical equipment supply chain, internet healthcare, hospital construction, hospital property management, and other medical industry chain services. The group has invested in the construction of Hainan Cancer Hospital, Hainan Chengmei Hospital, and Boao Super Hospital located in the international medical tourism pilot zone of Hainan Boao Lecheng, forming the "Chengmei Big Health Matrix" under the new pattern of Hainan Free Trade Port. (Wu Fengxu)